Top 15 Clover Biopharmaceuticals investors
The most complete profiles first. Showing 15 of 15.
David BonitaVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more
Verified email available
Geoffrey HsuVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Jonathan SilversteinVerified
Private Equity Firm · United States
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Jonathan WangVerified
Private Equity Firm · China
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Rishi GuptaVerified
Private Equity Firm · United States
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Carter Neild
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Chau Khuong
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more
Contact details available
Henry ChenVerified
Venture Capital, Private Equity Firm · Hong Kong
Health CareWearablesWellnessWomen FoundedPortfolio: Imperative Care, Rejoni, Intrinsic Therapeutics, Clover Biopharmaceuticals and 5 more
Verified email available
Scotland Stevens
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Anat Naschitz
Private Equity Firm · Israel
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Erez Chimovits
Private Equity Firm · Israel
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Matt Constantino
Venture Capital, Private Equity Firm · United States
Health CareWearablesWellnessWomen FoundedPortfolio: Imperative Care, Rejoni, Intrinsic Therapeutics, Clover Biopharmaceuticals and 5 more
Contact details available
Michael Rakiter
Venture Capital, Private Equity Firm · United States
Health CareWearablesWellnessWomen FoundedPortfolio: Imperative Care, Rejoni, Intrinsic Therapeutics, Clover Biopharmaceuticals and 5 more
Contact details available
Sampson Lau
Venture Capital, Private Equity Firm · Hong Kong
Health CareWearablesWellnessWomen FoundedPortfolio: Imperative Care, Rejoni, Intrinsic Therapeutics, Clover Biopharmaceuticals and 5 more
Contact details available
Tim Xiao, CFA, FRM
Venture Capital, Private Equity Firm
Health CareWearablesWellnessWomen FoundedPortfolio: Imperative Care, Rejoni, Intrinsic Therapeutics, Clover Biopharmaceuticals and 5 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
- Chinook Therapeutics10
- Janux Therapeutics10
- Visen Pharmaceuticals10
- Adagio Therapeutics10
- Pandion Therapeutics10
- MobileODT10
- AnchorDx10
- ReViral10
- CoreMap10
- Yisheng Biopharma10
- I-Mab Biopharma10
Frequently asked questions
How many Clover Biopharmaceuticals investors are on Angel Roster?
Angel Roster lists 15 Clover Biopharmaceuticals investors. 6 of them (40%) include a verified email address.
What types of investors are they?
The most common investor types are Private Equity Firms (15) and Venture Capital Firms (10). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Clover Biopharmaceuticals investors invest in?
Among those that list a stage, the most common are Series A (5) and Seed (5).
Where are Clover Biopharmaceuticals investors based?
Most are based in the United States (9), Israel (2) and Hong Kong (2).
Which companies have Clover Biopharmaceuticals investors backed?
The most-backed portfolio companies among them are Chinook Therapeutics (10), Janux Therapeutics (10), Visen Pharmaceuticals (10), Adagio Therapeutics (10) and Pandion Therapeutics (10).
How do I contact Clover Biopharmaceuticals investors?
Create a free Angel Roster account to search and filter all 15, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.